Summary
56 / 100 · Bulios Score
What speaks for it
- It could repay all its net debt from 0.0 years of operating profit.
- It has been profitable 6 years in a row.
What to watch
- Revenue fell by 10% a year over the last 3 years.
- It reports a profit, yet spends more cash than it brings in.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedPrice against the Bulios Fair Price
P/E against the industry (Chemicals - Specialty)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 19.9 INR for 1 INR of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (INR)
Diluted EPS (INR)
Revenue grew by 11% a year over 5 years. Over the last 3 years it fell by 10% a year. Earnings per share fell by 14% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 INR of revenue goes
- Cost of sales 95 INR
- Sales and administration 0.8 INR
- Taxes and other 0.7 INR
- Net profit 3.1 INR
Net profit, industry median (Chemicals - Specialty) 21 INR
Out of every 100 INR of revenue, 3.1 INR is left as net profit.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail